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R E C E P T O R - M E D I A T E D G E N E D E L I V E R Y INTO M A M M A L I A N 
C E L L S 
Ernst Wagner, Matt Cotten, Christian Plank, Karl Mechtler, Kur t 
Zatloukal, and Max L. Birnstiel 
Research Institute of Molecular Pathology, Vienna, Austria. 
We have developed gene transfer systems which use the receptor-
mediated endocytosis route to import DNA into mammalian cells. DNA 
gene constructs have been complexed with a polylysine-conjugated 
ligand (such as transferrin) for uptake via receptor-mediated 
endocytosis and polylysine-conjugated, endosome-disruption agents 
(such as replication-defective adenoviruses or peptides derived from 
the N-terminal sequence of influenza virus hemagglutinin) which allow 
cytoplasmic entry of the DNA. These complexes have been delivered to 
and expressed at very high level in a large proportion of target cells (up 
to 80% in primary fibroblasts, primary myoblasts or primary human 
melanoma cells). 
Key words: DNA transfection; gene therapy; gene transfer; endocytosis; 
transferrin; polylysine; endosome disruption; adenovirus; influenza 
peptide 
Introduct ion 
Our work has been based on the idea of adopting cellular transport 
mechanisms for the uptake of nucleic acids into cells. In order to exploit 
the transferrin receptor mediated endocytosis, the iron transport 
protein transferrin that has been chemically conjugated to the DNA-
binding polycation polylysine (1,2). Polylysine upon binding to the DNA 
also condenses it to a doughnut-like particle (3). The complexes have 
been found efficiently delivered into the endosomes of many types of 
cells. In some cell lines a high level gene expression has been found, in 
many cell types, however, low or no expression has been observed (4). Results 
It became clear that the DNA is accumulating in internal vesicles and 
subsequent steps that deliver the DNA to the nucleus work only 
inefficiently. Strategies had to be developed to prevent degradation of 
the DNA in lysosomal compartments and promote the transport to the 
nucleus. This has led to the development of an efficient gene transfer 
system (5) consisting of a transferrin-polylysine / DNA complex linked 
30 
to a replication-defective adenovirus (see Figure). After endocytosis of 
these combination complexes into endosomes the natural endosomal 
acidification process triggers a conformational change in adenoviral coat 
proteins which then destabilize the membranes; both the viral particle 
and the DNA are released to the cytoplasm. 
Adenovirus DNA Transfection 
F i g u r e : Formation (A) and uptake (B) of adenovirus-polylysine / 
transferrin-polylysine / DNA combination complexes into cells. 
The use of replication-defective and chemically (psoralen / U V ) 
inactivated adenovirus (6) avoids most of the potential hazards 
associated with viral vectors. The delivered gene is carried on the 
exterior of the adenovirus, being therefore far less restricted in size or 
sequence of the DNA to be delivered. Transfer of 48 kb DNA molecules, 
and high level expression of the full length (8 kb) human factor V I I I 
cDNA in primary fibroblasts, myoblasts and myotubes has been 
demonstrated. 
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A potential application of the gene transfer system may be the 
development of a cytokine gene-modified melanoma vaccine. This is 
supposed for application in patients with minimum residual disease 
where most of the tumor mass has been removed by surgery. A tumor 
cell culture has to be established, transfected with a immunstimulatory 
agent such as a cytokine gene, irradiated with 100 Gy in order to block 
replication. Such a cytokine-gene modified irradiated vaccine when 
injected s.c. into the patient is supposed to induce a systemic immune 
response against residual tumor cells that otherwise lead to metastasis 
formation. 
Cytokines are important actors in the activation of an immune response. 
Interleukin 2 (IL-2) is produced by stimulated T-helper cells that have 
seen e.g. tumor-antigen presented by cells such as macrophages or 
dendritic cells. IL-2 stimulates effector cells such as NK cells or CTLs 
that are able to circulate in the patients body and to eliminate residual 
tumor cells. IL-2 expressing tumor cells should have the ability to 
directly activate these effector cells. 
We have started first animal experiments in the M3 melanoma model. 
Murine M3 melanoma cells transfected with cytokine gene constructs 
produce high levels of cytokines (24,000 units IL-2 / 10^ cells/24 hrs; 
1200 ng I F N - γ / Ι Ο 6 cells/24 hrs). Transplantation of l x l O 5 IL-2 
transfected M3 cells into syngeneic DBA/2 mice showed loss of 
tumorigenicity (0/6 animals), whereas 6/6 animals treated with l x l O 5 
untransfected M3 cells developed tumors. In order to test a biological 
efficacy of the cancer vaccine, animals were immunized with irradiated, 
IL-2 transfected M3 cells. The vaccination resulted in a systemic 
protection in all animals against subsequent challenge with tumorigenic 
doses of unmodified M3 cells (7). 
Conclusions 
What are the future options? On the one hand we want to further 
develop the cancer vaccine into a stage suitable for a clinical trial, on 
the other hand we are developing completely synthetic versions of the 
gene transfer system. We have replaced the whole virus by small 
synthetic peptides similar to sequences occurring in the hemagglutinin 
of influenza virus. At neutral pH this peptide have an inactive, rather 
unordered structure, whereas at acidic, endosomal pH they adopt the 
active structure of an amphipathic helix that can interact with the lipid 
membrane and destabilize it . We have incorporated such endosome 
disruptive peptides into complexes containing DNA, transferrin and 
polylysine. The peptides within the complex are able to disrupt 
liposomes (8) or endosomal membranes (CP. and E.W., unpublished 
results) triggered by the change to lower pH and substantially (up to 
10,000-fold) augment the gene transfer (8,9). 
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PAPER OF WAGNER 
S p i e r : While r e c o g n i s i n g t h a t the i n t r o d u c t i o n of 
exogenous genes i n t o animal c e l l s i s 
important have you examined the moral 
i s s u e s i n v o l v e d i n the use of such 
t e c h n i q u e s f o r the enhancement of human 
f u n c t i o n s r a t h e r than the a l l e v i a t i o n of 
d i s e a s e ? 
Wagner: The concept of our work i s t h a t i t i s not 
the permanent t r a n s f e r of genes i n t o 
c e l l s . We chose the a p p l i c a t i o n s of the 
tumour v a c c i n e s because once i t has worked 
t h e r e w i l l not be any g e n t i c a l l y modified 
c e l l s remaining i n the p a t i e n t . The gene 
t r a n s f e r s we use l e a d t o episomal DNA and 
not i n t e g r a t e d DNA. 
34 
